Interleukin-2 gene transduction into freshly isolated lung adenocarcinoma cells with adenoviral vectors

Human Gene Therapy

Volumn 8, Issue 1, 1997, Pages 1-14

  Heike, Yuji ^a   Takahashi, Minako ^a   Kanegae, Yumi ^b   Sato, Yumi ^b   Saito, Izumu ^b   Saijo, Nagahiro ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; BETA GALACTOSIDASE; INTERLEUKIN 2;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CENTRIFUGATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOMEGALOVIRUS; EXPRESSION VECTOR; FEMALE; GENE EXPRESSION; GENE THERAPY; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; MOUSE; NONHUMAN; NORMAL HUMAN; PLEURA EFFUSION; PROMOTER REGION; PROTEIN SECRETION; SERUM; TUMOR IMMUNITY;

EID: 0031034984     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.1-1     Document Type: Article

References (75)

1. AKLI, S., CAILLAUD C., VIGNE, E., STRATFORD-PERRICAUDET, L.D., POENARU, L., PERRICAUDET, M., KAHN, A., and PESCHANSKI, M.R. (1993). Transfer of a foreign gene into the brain using adenovirus vectors [see comments]. Nature Genet. 3, 224-228.
2. ASHER, A.L., MULE, J.J., KASID, A., RESTIFO, N.P., SALO, J.C., REICHERT, C.M., JAFFE, G., FENDLY, B., KRIEGLER, M., and ROSENBERG, S.A. (1991). Murine tumor cells transduced with the gene for tumor necrosis factor-alpha. Evidence for paracrine immune effects of tumor necrosis factor against tumors. J. Immunol. 146, 3227-3234.
3. BELLDESGRUN, A., TSO, C.L., SAKATA, T., DUCKETT, T., BRUNDA, M.J., BARSKY, S.H., CHAI, J., KABOO, R., LAVEY, R.S., MCBRIDE, W.H., and DEKERNION, J.B. (1993) Human renal carcinoma line transfected with interleukin-2 and/or Interferon alpha gene(s): Implications for live cancer vaccines. J. Natl. Cancer Inst. 85, 207-216.
4. BOUT, A., PERRICAUDET, M., BASKIN, G., IMLER, J.L., SCHOLTE, B.J., PAVIRANI, A., and VALERIO, D. (1994). Lung gene therapy: In vivo adenovirus-mediated gene transfer to rhesus monkey airway epithelium. Hum. Gene Ther. 5, 3-10.
5. BRODY, S.L., JAFFE, H.A., HAN, S.K., WERSTO, R.P., and CRYSTAL, R.G. (1994a). Direct in vivo gene transfer and expression in malignant cells using adenovirus vectors. Hum. Gene Ther. 5, 437-447.
6. BRODY, S.L., METZGER, M., DANEL, C., ROSENFELD, M.A., and CRYSTAL, R.G. (1994b). Acute responses of non-human primates to airway delivery of an adenovirus vector containing the human cystic fibrosis transmembrane conductance regulator cDNA. Hum. Gene Ther. 5, 821-836.
7. CAILLAUD, C., AKLI, S., VIGNE, E., KOULAKOFF, A., PERRICAUDET, M., POENARU, L., KAHN, A., and BERWALD-NETTER, Y. (1993). Adenoviral vector as a gene delivery system into cultured rat neuronal and glial cells. Eur. J. Neurosci. 5, 1287-1291.
8. CHEN, S.H., SHINE, H.D., GOODMAN, J.C., GROSSMAN, R.G., and WOO, S.L. (1994). Gene therapy for brain tumors: Regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc. Natl. Acad. Sci. USA 91, 3054-3057.
9. COLIGAN, J.E., KRUISBEEK, A.M., SHEVACH, E.M., and STROBER, W. (1992). Measurement of human and murine IL-2 and IL-4. In Current Protocols in Immunology. (John Wiley & Sons, Inc., New York) pp. 6.3.2-6.3.6.
10. CRISTIANO, R.J., SMITH, L.C., KAY, M.A., BRINKLEY, B.R., and WOO, S.L. (1993). Hepatic gene therapy: Efficient gene delivery and expression in primary hepatocytes utilizing a conjugated adenovirus-DNA complex. Proc. Natl. Acad. Sci. USA 90, 11548-11552.
11. CRYSTAL, R.G., MCELVANEY, N.G., ROSENFELD, M.A., CHU, C.S., MASTRANGELI, A., HAY, J.G., BRODY, S.L., JAFFE, H.A., EISSA, N.T., and DANEL, C. (1994). Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis. Nature Genet. 8, 42-51.
12. DAVIDSON, B.L., ALLEN, E.D., KOZARSKY, K.F., WILSON, J.M., and ROESSLER, B.J. (1993). A model system for in vivo gene transfer into the central nervous system using an adenoviral vector [see comments]. Nature Genet. 3, 219-223.
13. DRANOFF, G., JAFFEE, E., LAZENBY, A., GOLUMBEK, P., LEVITSKY, H., BROSE, K., JACKSON, V., HAMADA, H., PARDOLL, D., and MULLIGAN, R.C. (1993). Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. USA 90, 3539-3543.
14. DRAZAN, K.E., SHEN, X.D., CSETE, M.E., ZHANG, W.W., ROTH, J.A., BUSUTTIL, R.W., and SHARED, A. (1994). In vivo adenoviral-mediated human p53 tumor suppressor gene transfer and expression in rat liver after resection. Surgery 116, 197-203.
15. ENGELHARDT, J.F., SIMON, R.H., YANG, Y., ZEPEDA, M., WEBER-PENDELETON, S., DORANZ, B., GROSSMAN, M., and WILSON, J.M. (1993). Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: biological efficacy study. Hum. Gene Ther. 4, 759-769.
16. ENGELHARDT, J.F., YE, X., DORANS, B., and WILSON, J.M. (1994). Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc. Natl. Acad. Sci. USA 91, 6196-6200.
17. ERZURUM, S.C., LEMARCHAND, P., ROSENFELD, M.A., YOO, J.H., and CRYSTAL, R.G. (1993). Protection of human endothelial cells from oxidant injury by adenovirus-mediated transfer of the human catalase cDNA. Nucleic Acids Res. 21, 1607-1612.
18. FIDLER, I.J. (1975). Biological behavior of malignant melanoma cells correlated to their survival in vivo. Cancer Res. 35, 218-224.
19. GANSBACHER, B., ZIER, K., DANIELS, B., CRONIN, K., BANNERJI, R., and GILBOA, E. (1990). Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity. J. Exp. Med. 172, 1217-1224.
20. GAO, L., WAGNER, E., COTTEN, M., AGARWAL, S., GARRIS, C., ROMER, M., MILLER, L., HU, P.C., and CURIEL, D. (1993). Direct in vivo gene transfer to airway epithelium employing adenovirus-polylysine-DNA complexes. Hum. Gene Ther. 4, 17-24.
21. GAUGLER, B., VAN DEN EYNDE, B., VAN DER BRUGGEN, P., ROMERO, P., GAFORIO, J.J., DE PLAEN, E., LETHE, B., BRASSEUR, F., and BOON, T. (1994). Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. Exp. Med. 179, 921-930.
22. GOMEZ-FOIX, A.M., COATS, W.S., BAQUE, S., ALAM, T., GERARD, R.D., and NEWGARD, C.B. (1992). Adenovirus-mediated transfer of the muscle glycogen phosphorylase gene into hepatocytes confers altered regulation of glycogen metabolism. J. Biol. Chem. 267, 25129-25134.
23. GOLUMBEK, P.T., LAZENBY, A.J., LEVITSKY, H.I., JAFFEE, L.M., KARASUYAMA, H., BAKER, M., and PARDOLL, D.M. (1991). Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4. Science 254, 713-716.
24. HADDADA, H., RAGOT, T., CORDIER, L., DUFFOUR, M.T., and PERRICAUDET, M. (1993). Adenoviral interleukin-2 gene transfer into P815 tumor cells abrogates tumorigenicity and induces antitumoral immunity in mice. Hum. Gene Ther. 4, 703-711.
25. HEIKE, Y., TAKAHASHI, M., OHIRA, T., ARIOKA, H., FUNAYAMA, Y., NISHIO, K. OGASAWARA, H., and SAIJO, N. (1995). In vivo screening models of cisplatin-resistant human lung cancer cell lines using SCID mice. Cancer Chemother. Pharmacol. 35, 200-204.
26. JAFFE, H.A., DANEL, C., LONGENECKER, G., METZGER, M., SETOGUCHI, Y., ROSENFELD, M.A., GANT, T.W., THORGEIRSSON, S.S., STRATFORD-PERRICAUDET, L.D., PERRICAUDET, M., PAVIRANI, A., LECOCQ, J.-P., and CRYSTAL, R.G. (1992). Adenovirus-mediated in vivo gene transfer and expression in normal rat liver. Nature Genet. 1, 372-378.
27. KAISER, L.L. (1996). Gene therapy for thoracic malignancies. (Abstract). Proceedings of 5th IASLC Lung Tumor Biology Workshop.
28. KASS-EISLER, A., FALCK-PEDERSEN, E., ALVIRA, M., RIVERA, J., BUTTRICK, P.M., WITTENBERG, B.A., CIPRIANI, L., and LEINWAND, L.A. (1993). Quantitative determination of adenovirus-mediated gene delivery to rat cardiac myocytes in vitro and in vivo. Proc. Natl. Acad. Sci. USA 90, 11498-11502.
29. KAWAKAMI, Y., ELIYAHU, S., DELGADO, C.H., ROBBINS, P.F., RIBOLTINI, L., TOPALIAN, S.L., MIKI, T., and ROSENBERG, S.A. (1994a). Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc. Natl. Acad. Sci. USA 91, 3515-3519.
30. KAWAKAMI, Y., ELIYAHU, S., SAKAGUCHI, K., ROBBINS, P.F., RIVOLTINI, L., YANNELLI, J.R., APPELLA, E., and ROSENBERG, S.A. (1994b). Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J. Exp. Med. 180, 347-352.
31. KIM, D.W., UETSUKI, T., KAZIRO, Y., YAMAGUCHI, J., and SUGANO, S. (1990). Use of the human elongation factor 1 alpha promoter as a versatile and efficient expression system. Gene 91, 217-223.
32. KOZARSKY, K., GROSSMAN, M., and WILSON, J.M. (1993). Adenovirus-mediated correction of the genetic defect in hepatocytes from patients with familial hypercholesterolemia. Somat. Cell Mol. Genet. 19, 449-458.
33. KOZARSKY, K.F., MCKINLEY, D.R., AUSTIN, L.L., RAPER, S.E., STRATFORD-PERRICAUDET, L.D., and WILSON, J.M. (1994). In vivo correction of low density lipoprotein receptor deficiency in the Watanabe heritable hyperlipidemic rabbit with recombinant adenoviruses. J. Biol. Chem. 269, 13695-13702.
34. LATRON, F., PAZMANY, L., MORRISON, J., MOOTS, R., SAFER, M.A., MCMICHAEL, A., and STROMINGER, J.L. (1992). A critical role for conserved residues in the cleft of HLA-A2 in presentation of a nonapeptide to T cells. Science 257, 964-967.
35. LE GAL LA SALLE, G., ROBERT, J.J., BERRARD, S., RIDOUX, V., STRATFORD-PERRICAUDET, L.D., PERRICAUDET, M., and MALLET, J. (1993). An adenovirus vector for gene transfer into neurons and glia in the brain. Science 259, 988-990.
36. LEMARCHAND, P., JAFFE, H.A., DANEL, C., CID, M.C., KLEINMAN, H.K., STRATFORD-PERRICAUDET, L.D., PERRICAUDET, M., PAVIRANI, A., LECOCQ, J.P., and CRYSTAL, R.G. (1992). Adenovirus-mediated transfer of a recombinant human alpha 1-antitrypsin cDNA to human endothelial cells. Proc. Natl. Acad. Sci. USA 89, 6482-6486.
37. LEMARCHAND, P., JONES, M., YAMADA, I., and CRYSTAL, R.G. (1993). In vivo gene transfer and expression in normal uninjured blood vessels using replication-deficient recombinant adenovirus vectors. Circ. Res. 72, 1132-1138.
38. MAEDA, H., DANEL, C., and CRYSTAL, R.G. (1994). Adenovirus-mediated transfer of human lipase complementary DNA to the gallbladder [see comments]. Gastroenterology 106, 1638-1644.
39. MASTRANGELI, A., O'CONNELL, B., ALADIB, W., FOX, P.C., BAUM, B.J., and CRYSTAL, R.G. (1994). Direct in vivo adenovirus-mediated gene transfer to salivary glands. Am. J. Physiol. 266, 1146-1155.
40. MITTEREDER, N., YEI, S., BACHURSKI, S., CUPPOLETTI, J., WHITSETT, J.A., TOLSTOSHEV, P., and TRAPNELL, B.C. (1994). Evaluation of the efficacy and safety of in vitro, adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA. Hum. Gene Ther. 5, 717-729.
41. MIYAKE, S., MAKIMURA, M., KANEGAE, Y., HARADA, S., SATO, Y., TAKAMORI, K., TOKUDA, C., and SAITO, I. (1996). Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid vearing full-length virus genome. Proc. Natl. Acad. Sci. USA 93, 1320-1324.
42. NIWA, H., YAMAMURA, K., and MIYAZAKI, J. (1991). Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108, 193-199.
43. OHE, Y., PODACK, E.R., OLSEN, K.J., MIYAHARA, Y., OHIRA, T., MIURA, K., NISHIO, K., and SAIJO, N. (1993). Combination effect of vaccination with IL2 and IL4 cDNA transfected cells on the induction of a therapeutic immune response against Lewis lung carcinoma cells. Int. J. Cancer 53, 432-437.
44. OHIRA, T., OHE, Y., HEIKE, Y., PODACK, E.R., OLSEN, K.J., NISHIO, K., NISHIO, M., MIYAHARA, Y., FUNAYAMA, Y., OGASAWARA, H., ARIOKA, H., KUNIKANE, H., FUKUDA, M., KATO, H., and SAIJO, N. (1994). In vitro and in vivo growth of B16F10 melanoma cells transfected with interleukin-4 cDNA and gene therapy with the transfectant. J. Cancer Res. Clin. Oncol. 120, 631-635.
45. PATEL, P.M., FLEMMING, C.L., FISHER, C., PORTER, C.D., THOMAS, J.M., GORE, M.E., and COLLINS, M.K. (1994). Generation of interleukin-2-secreting melanoma cell populations from resected metastatic tumors. Hum. Gene Ther. 5, 577-584.
46. PORGADOR, A., BANNERJI, R., WATANABE, Y., FELDMAN, M., GILBOA, E., and EISENBACH, L. (1993). Antimetastatic vaccination of tumor-bearing mice with two types of IFN-gamma gene-inserted tumor cells. J. Immunol. 150, 1453-1470.
47. ROSENFELD, M.A., YOSHIMURA, K., TRAPNELL, B.C., YONEYAMA, K., ROSENTHAL, E.R., DALEMANS, W., FUKAYAMA, M., FARGON, J., STIER, L.E., STRATFORD-PERRICAUDET, L.D., PERRICAUDET, M., GUGGINO, W.B., PAVIRANI, A., LECOQ, J.-P., and CRYSTAL, R.G. (1992). In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 68, 143-155.
48. ROSENFELD, M.A., CHU, C.S., SETH, P., DANEL, C., BANKS, T., YONEYAMA, K., YOSHIMURA, K., and CRYSTAL, R.G. (1994). Gene transfer to freshly isolated human respiratory epithelial cells in vitro using a replication-deficient adenovirus containig the human cystic fibrosis transmembrane conductance regulator cDNA. Hum. Gene Ther. 5, 331-342.
49. ROSENTHAL, F.M., CRONIN, K., BANNERJI, R., GOLDE, D.Q., and GANSBACHER, B. (1994). Augmentation of antitumor immunity by tumor cells transduced with a retroviral vector carrying the interleukin-2 and interferon-gamma cDNAs. Blood 83, 1289-1298.
50. SAITO, I., OYA, Y., YAMAMOTO, K., YUASA, T., and SHIMOJO, H. (1985). Construction of nondefective adenovirus type 5 bearing a 2.8-kilobase hepatitis B virus DNA near the right end of its genome. J. Virol. 54, 711-719.
51. SETOGUCHI, Y., DANEL, C., and CRYSTAL, R.G. (1994a). Stimulation of erythropoiesis by in vivo gene therapy: Physiologic consequences of transfer of the human erythropoietin gene to experimental animals using an adenovirus vector. Blood 84, 2946-2953.
52. SETOGUCHI, Y., JAFFE, H.A., CHU, C.S., and CRYSTAL, R.G. (1994b). Intraperitoneal in vivo gene therapy to deliver alpha 1-antitrypsin to the systemic circulation. Am. J. Respir. Cell Mol. Biol. 10, 369-377.
53. SETOGUCHI, Y., JAFFE, H.A., DANEL, C., and CRYSTAL, R.G. (1994c). Ex vivo and in vivo gene transfer to the skin using replication-deficient recombinant adenovirus vectors. J. Invest. Dermatol. 102, 415-421.
54. SIMON, R.H., ENGELHARDT, J.F., YANG, Y., ZEPEDA, M., WEBER-PENDELTON, S., GROSSMAN, M., and WILSON, J.M. (1993). Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: Toxicity study. Hum. Gene Ther. 4, 771-780.
55. SLINGLUFF, C. JR., COX, A.L., STOVER, J. JR., MOORE, M.M., HUNT, D.F., and ENGELHARD, V.H. (1994). Cytotoxic T-lymphocyte response to autologous human squamous cell cancer of the lung: epitope reconstitution with peptides extracted from HLA-Aw68. Cancer Res. 54, 2731-2737.
56. SMITH, T.A., MEHAFFEY, M.G., KAYDA, K.B., SAUNDERS, J.M., YEI, S., TRAPNELL, B.C., MCCLELLAND, A., and KALEKO, M. (1993). Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice. Nature Genet. 5, 397-402.
57. SMYTHE, W.R., HWANG, H.C., AMIN, K.M., ECK, S.L., DAVIDSON, B.L., WILSON, J.M., KAISER, L.R., and ALBELDA, S.M. (1994a). Use of recombinant adenovirus to transfer the herpes simplex virus thymidine kinase (HSVtk) gene to thoracic neoplasms: An effective in vitro drug sensitization system. Cancer Res. 54, 2055-2059.
58. SMYTHE, W.R., KAISER, L.R., HWANG, H.C., AMIN, K.M., PILEWSKI, J.M., ECK, S.J., WILSON, J.M., and ALBELDA, S.M. (1994b). Successful adenovirus-mediated gene transfer in an in vivo model of human malignant mesothelioma [see comments]. Ann. Thorac. Surg. 57, 1395-1401.
59. SUGIURA, D., and STOCK, C.C. (1955). Studies in a tumor spectrum. III. The effect of phosphoramides on the growth of a variety of mouse and rat. Cancer Res. 5, 38-51.
60. TAKEBE, Y., SEIKI, M., FUJISAWA, J., HOY, P., YOKOTA, K., ARAI, K., YOSHIDA, M., and ARAI, N. (1988). SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat. Mol. Cell. Biol. 8, 466-472.
61. TRAVERSARI, C., VAN DER BRUGGEN, P., LUESCHER, I.F., LURQUIN, C., CHOMEZ, P., VAN PEL, A., DE PLAEN, E., AMAR-COSTESEC, A., and BOON, T. (1992). A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J. Exp. Med. 176, 1453-1457.
62. VAN DER BRUGGEN, P., TRAVERSARI, C., CHOMEZ, P., LURQUIN, C., DE PLAEN, E., VAN DEN EYNDE, B., KNUTH, A., and BOON, T. (1991). A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254, 1643-1647.
63. VAN DER BRUGGEN, P., BASTIN, J., GAJEWSKI, T., COULIE, P.G., BOEL, P., DE SMET, C., TRAVERSARI, C., TOWNSEND, A., and BOON, T. (1994a). A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Eur. J. Immunol. 24, 3038-3043.
64. VAN DER BRUGGEN, P., SZIKORA, J.P., BOEL, P., WILDMANN, C., SOMVILLE, M., SENSI, M., and BOON, T. (1994b). Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA-Cw*1601. Eur. J. Immunol. 24, 2134-2140.
65. WATANABE, Y., KURIBAYASHI, K., MIYATAKE, S., NISHIHARA, K., NAKAYAMA, E., TANIYAMA, T., and SAKATA, T. (1989). Exogenous expression of mouse interferon gamma cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented anti-tumor immunity. Proc. Natl. Acad. Sci. USA 86, 9456-9460.
66. WELSH, M.J., SMITH, A.E., ZABNER, J., RICH, D.P., GRAHAM, S.M., GREGORY, R.J., PRATT, B.M., and MOSCICKI, R.A. (1994). Cystic fibrosis gene therapy using an adenovirus vector: in vivo safety and efficacy in nasal epithelium. Hum. Gene Ther. 5, 209-219.
67. WIEDENFELD, E.A., FERNANDEZ-VINA, M., VERZODSKY, J.A., and CARBONE, D.P. (1994). Evidence for selection against human lung cancers bearing p53 missense mutations which occur within the HLA A*0201 peptide consensus motif. Cancer Res. 54, 1175-1177.
68. YASUMOTO, K., and OGURA, T. (1991). Intrapleural application of recombinant interleukin-2 in patients with malignant pleurisy due to lung cancer: A multi-institutional cooperative study. Biotherapy 3, 345-349.
69. + cytotoxic T-cells. Cancer Res. 53, 3257-3261.
70. YANG, Y., NUNES, F.A., BERENCSI, K., GONCZOL, E., ENGELHARDT, J.F., and WILSON, J.M. (1994). Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nature Genet. 7, 362-369.
71. YEI, S., MITTEREDER, N., WERT, S., WHISETT, J.A., WILMOTT, R.W., and TRAPNELL, B.C. (1994). In vivo evaluation of the safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lung. Hum. Gene Ther. 5, 731-744.
72. YOSHINO, I., GOEDEGEBUURE, P.S., PEOPLES, G.E., PARIKH, A.S., DIMAIO, J.M., LYERLY, H.K., GAZDAR, A.F., and EBERLEIN, T.J. (1994). HER2/neu-derived peptides are shared antigens among human non-small cell lung cancer and ovarian cancer. Cancer Res. 54, 3387-3390.
73. ZABNER, J., COUTURE, L.A., GREGORY, R.J., GRAHAM, S.M., SMITH, A.E., and WELSH, M.J. (1993). Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelial of patients with cystic fibrosis. Cell 75, 207-216.
74. ZABNER, J., COUTURE, L.A., SMITH, A.E., and WELSH, M.J. (1994a). Safety and efficacy of repetitive adenovirus-mediated transfer of CFTR cDNA to airway epithelial of primates and cotton rats. Nature Genet. 6, 75-83.
75. ZABNER, J., COUTURE, L.A., SMITH, A.E., and WELSH, M.J. (1994b). Correction of cAMP-stimulated fluid secretion in cystic fibrosis airway epithelia: Efficiency of adenovirus-mediated gene transfer in vitro. Hum. Gene Ther. 5, 585-593.